Indication

Severe chronic neutropenia

Severe chronic neutropenia refers to a heterogeneous group of hematologic disorders affecting the immune and hematopoietic systems, characterized by a persistent or cyclic reduction in the absolute neutrophil count below 500 cells per microliter lasting for at least three months. Read more about Severe chronic neutropenia

8 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Severe chronic neutropenia therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Severe chronic neutropenia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Severe chronic neutropenia.

Severe chronic neutropenia refers to a heterogeneous group of hematologic disorders affecting the immune and hematopoietic systems, characterized by a persistent or cyclic reduction in the absolute neutrophil count below 500 cells per microliter lasting for at least three months.

It affects both pediatric and adult populations and encompasses distinct subtypes, including congenital, cyclic, and idiopathic forms.

Pathophysiologically, the condition often stems from genetic mutations—such as in the ELANE gene—or autoimmune processes that cause myeloid maturation arrest in the bone marrow or accelerated peripheral neutrophil destruction.

Clinically, this profound neutrophil deficiency impairs host defense against pathogens, predisposing individuals to recurrent fevers, mucosal ulcerations, cellulitis, and life-threatening systemic bacterial infections.

Personalize your experience

Follow Severe chronic neutropenia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it